The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma
It was the aim of our study to examine the clinical significance of t(14;18)-positive cells in samples from 47 patients with follicular non-Hodgkin’s lymphoma (NHL) who underwent high-dose therapy with autologous peripheral blood stem cell (PBSC) transplantation. At the time of PBSC mobilization, 25...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
08 December 1998
|
| In: |
Leukemia
Year: 1998, Jahrgang: 12, Heft: 12, Pages: 1971-1976 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/sj.leu.2401242 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.leu.2401242 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/2401242 
|
| Verfasserangaben: | M. Moos, R. Schulz, S. Martin, A. Benner, R. Haas |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 192564538X | ||
| 003 | DE-627 | ||
| 005 | 20250717013647.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250514s1998 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.leu.2401242 |2 doi | |
| 035 | |a (DE-627)192564538X | ||
| 035 | |a (DE-599)KXP192564538X | ||
| 035 | |a (OCoLC)1528045407 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Moos, Marion |e VerfasserIn |0 (DE-588)1243124318 |0 (DE-627)1773573187 |4 aut | |
| 245 | 1 | 4 | |a The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma |c M. Moos, R. Schulz, S. Martin, A. Benner, R. Haas |
| 264 | 1 | |c 08 December 1998 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.05.2025 | ||
| 520 | |a It was the aim of our study to examine the clinical significance of t(14;18)-positive cells in samples from 47 patients with follicular non-Hodgkin’s lymphoma (NHL) who underwent high-dose therapy with autologous peripheral blood stem cell (PBSC) transplantation. At the time of PBSC mobilization, 25 patients were in first remission, while 22 patients had a history of previous treatment failure. At the same time, 43 patients had polymerase chain reaction (PCR)-positive cells in samples from bone marrow (BM) and/or peripheral blood (PB). Independent of the remission status, high-dose cytarabine and mitoxantrone with granulocyte colony-stimulating factor (G-CSF) support were administered for PBSC mobilization. Following high-dose conditioning therapy which consisted of cyclophosphamide (200 mg/kg) and hyperfractionated total body irradiation (TBI, 14.4 Gy) or BEAM (carmustine, etoposide, cytarabine, melphalan), 34 patients received PCR-positive and 13 patients received PCR-negative autografts. After a median follow-up time of 20 months (range, 6-50) post-transplantation, 33 patients were in remission, while 14 patients had relapsed after a median time of 14.5 months (range, 10-42). Using the Andersen-Gill proportional hazards regression model for the analysis of relapse-free survival, we found that PCR-positive findings in samples from BM and/or PB at any given time-point after transplantation were associated with an increased estimated hazard ratio of 4.5 in comparison with a PCR-negative finding (P = 0.013). On the other hand, patients included while they were in first remission had a smaller estimated hazard ratio of 0.3 when compared with patients with a history of previous treatment failure (P = 0.048). For the latter group of patients, this translates into a significantly smaller probability of relapse-free survival in comparison to patients who were in first remission at the time of PBSC-mobilization (P = 0.012). In conclusion, the remission status of the patients before autografting and the PCR status as assessed on the occasion of follow-up examinations are significant prognostic parameters for relapse-free survival in patients with follicular lymphoma undergoing high-dose therapy with PBSC autografting. | ||
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a general | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Intensive / Critical Care Medicine | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Medicine/Public Health | |
| 650 | 4 | |a Oncology | |
| 700 | 1 | |a Schulz, Renate |e VerfasserIn |0 (DE-588)119825307X |0 (DE-627)1680568426 |4 aut | |
| 700 | 1 | |a Martin, Simona |d 1963- |e VerfasserIn |0 (DE-588)123077974 |0 (DE-627)706152034 |0 (DE-576)293545456 |4 aut | |
| 700 | 1 | |a Benner, Axel |d 1959- |e VerfasserIn |0 (DE-588)106584686X |0 (DE-627)81687221X |0 (DE-576)425536602 |4 aut | |
| 700 | 1 | |a Haas, Rainer |d 1955- |e VerfasserIn |0 (DE-588)173773524 |0 (DE-627)698678141 |0 (DE-576)134613805 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 12(1998), 12, Seite 1971-1976 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma |
| 773 | 1 | 8 | |g volume:12 |g year:1998 |g number:12 |g pages:1971-1976 |g extent:6 |a The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.leu.2401242 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/2401242 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250514 | ||
| 993 | |a Article | ||
| 994 | |a 1998 | ||
| 998 | |g 173773524 |a Haas, Rainer |m 173773524:Haas, Rainer |d 910000 |d 910100 |e 910000PH173773524 |e 910100PH173773524 |k 0/910000/ |k 1/910000/910100/ |p 5 |y j | ||
| 998 | |g 106584686X |a Benner, Axel |m 106584686X:Benner, Axel |d 50000 |e 50000PB106584686X |k 0/50000/ |p 4 | ||
| 998 | |g 123077974 |a Martin, Simona |m 123077974:Martin, Simona |d 910000 |d 910100 |e 910000PM123077974 |e 910100PM123077974 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1243124318 |a Moos, Marion |m 1243124318:Moos, Marion |d 910000 |d 910100 |e 910000PM1243124318 |e 910100PM1243124318 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN192564538X |e 4724338903 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["M. Moos, R. Schulz, S. Martin, A. Benner, R. Haas"]},"note":["Gesehen am 14.05.2025"],"recId":"192564538X","id":{"eki":["192564538X"],"doi":["10.1038/sj.leu.2401242"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"08 December 1998","dateIssuedKey":"1998"}],"physDesc":[{"extent":"6 S."}],"person":[{"display":"Moos, Marion","family":"Moos","given":"Marion","role":"aut"},{"role":"aut","given":"Renate","family":"Schulz","display":"Schulz, Renate"},{"family":"Martin","display":"Martin, Simona","given":"Simona","role":"aut"},{"display":"Benner, Axel","family":"Benner","given":"Axel","role":"aut"},{"given":"Rainer","display":"Haas, Rainer","family":"Haas","role":"aut"}],"title":[{"title":"The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma","title_sort":"remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma"}],"relHost":[{"origin":[{"publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedDisp":"1997-"}],"language":["eng"],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"12","year":"1998","extent":"6","pages":"1971-1976","text":"12(1998), 12, Seite 1971-1976","volume":"12"},"disp":"The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphomaLeukemia","recId":"32046699X","pubHistory":["Nachgewiesen 11.1997 -"],"note":["Gesehen am 15.03.04"]}]} | ||
| SRT | |a MOOSMARIONREMISSIONS0819 | ||